Disclosing the physiology of pulp tissue for vital pulp therapy

The discovery that dentine is a reservoir of bioactive molecules that can be recruited on demand has attracted efforts to develop new protocols and materials for vital pulp therapy (VPT). The noncollagenous proteins (NCPs) present in the dentine extracellular matrix (ECM) include growth factors (TGF‐β1, BMP‐7, FGF‐2, IGF‐1 and IGF‐2, NGF and GDNF), extracellular matrix molecules (DSP, DPP, BSP, DMP‐1 and DSPP) and both anti‐inflammatory and pro‐inflammatory chemokines and cytokines (TNF‐α, IL‐1, IL‐6 and IL‐10). Molecules such as DSP and DPP are mainly expressed by odontoblasts, and they are cleaved products from dentine sialophosphoprotein (DSPP). Some molecules, such as TGF‐β1, specifically interact with decorin/biglycan in dentine. Although TGF‐β1 increases the expression and secretion of NGF in human pulp cells, NGF induces mineralization and increases the expression of DSPP and DMP‐1. Furthermore, GDNF may act as a cell survival factor and mitogen during tooth injury and repair. Pulp capping materials, such as MTA and calcium hydroxide, can solubilize bioactive dentine molecules (TGF‐β1, NGF and GDNF) that stimulate tertiary dentinogenesis. The binding of these signalling molecules leads to activation of several signalling transduction pathways involved in dentinogenesis, odontoblast differentiation and inflammatory responses, such as the p38 MAPK, NF‐kβ and Wnt/β‐catenin signalling pathways. Understanding the cascade of cellular and molecular events underlying the repair and regeneration processes provides a reasonable new approach to VPT through a targeted interaction between tooth tissue and bioactive molecules.